- Trials with a EudraCT protocol (38)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
38 result(s) found for: Type II Collagen.
Displaying page 1 of 2.
EudraCT Number: 2011-006123-37 | Sponsor Protocol Number: SI-C-019 | Start Date*: 2012-06-06 | |||||||||||
Sponsor Name:Solvotrin Innovations Ltd | |||||||||||||
Full Title: Impact of Eplerenone on Asymptomatic Left Ventricular Diastolic Dysfunction in Diabetic Patients | |||||||||||||
Medical condition: Asymptomatic left ventricular diastolic dysfunction in diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005999-13 | Sponsor Protocol Number: D8180C00034 | Start Date*: 2008-02-21 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A Phase II, Randomised, Open-label, Pilot Study to Evaluate the Safety and the Effects on Bone Resorption of AZD0530 in Patients with Prostate Cancer or Breast Cancer with Metastatic Bone Disease ... | ||
Medical condition: Prostate Cancer or Breast Cancer with Metastatic Bone Disease Cáncer de próstata o de mama con metástasis óseas | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) GB (Completed) SE (Completed) PT (Completed) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002387-16 | Sponsor Protocol Number: SI-C-060 | Start Date*: 2015-11-16 | |||||||||||
Sponsor Name:Solvotrin Innovations Ltd | |||||||||||||
Full Title: The Role of Tetracyclines in the Personalised Management of MMP-9 and Cardiovascular Function in Type 2 Diabetes | |||||||||||||
Medical condition: Type II diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003890-91 | Sponsor Protocol Number: BIOOPA | Start Date*: 2020-09-29 | |||||||||||
Sponsor Name:Medical University of Warsaw | |||||||||||||
Full Title: The development of innovative advanced therapy medicinal product (biological dressing of the human race) in the treatment of Epidermolysis Bullosa (EB) and other chronic wounds. | |||||||||||||
Medical condition: BIOOPA dressing will be used in the treatment of wounds in the course of Epidermolysis Bullosa, chronic venous leg ulceration and thermal injury (second degree burn). | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001284-40 | Sponsor Protocol Number: 160315 | Start Date*: 2015-05-20 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: The effect of liraglutide on bone turnover, bone mass and bone cell function | |||||||||||||
Medical condition: Type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003699-60 | Sponsor Protocol Number: KIBB01 | Start Date*: 2018-09-28 |
Sponsor Name:Karolinska Institutet | ||
Full Title: An exploratory, open label, multiple dose, multicentre phase I/II trial evaluating safety and efficacy of postnatal or prenatal and postnatal intravenous administration of allogeneic expanded fetal... | ||
Medical condition: Treatment of Osteogenesis Imperfecta (OI) type III and severe type IV. | ||
Disease: | ||
Population Age: In utero, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Temporarily Halted) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000674-30 | Sponsor Protocol Number: 2013-000674-30 | Start Date*: 2013-07-24 |
Sponsor Name:AOU SAN LUIGI GONZAGA - SCDU ONCOLOGIA MEDICA | ||
Full Title: Multicenter clinical trial, randomized phase II "window of opportunity" which aims to test the biological activity of abiraterone acetate administered as neoadjuvant therapy in patients with prosta... | ||
Medical condition: PROSTATE CANCER PATIENTS WITH HIGH RISK | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001411-71 | Sponsor Protocol Number: R475-OA-1815 | Start Date*: 2018-12-03 | |||||||||||
Sponsor Name:Regeneron Pharmaceuticals, Inc. | |||||||||||||
Full Title: Study to Evaluate Synovial Fluid in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip | |||||||||||||
Medical condition: Pain due to osteoarthritis of the knee | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004604-19 | Sponsor Protocol Number: CAR-ERA | Start Date*: 2014-08-06 | |||||||||||
Sponsor Name:Heinrich-Heine-Universität Düsseldorf | |||||||||||||
Full Title: Delayed Gadolinium-enhanced Magnetic resonance Imaging (MRI) of Cartilage - A pilot study to measure the effect of Adalimumab plus Methotrexat (MTX) versus Placebo plus MTX on cartilage in early rh... | |||||||||||||
Medical condition: patients with early progressive rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000605-72 | Sponsor Protocol Number: CB+MSCforEB | Start Date*: 2014-02-06 |
Sponsor Name:Universitair Medisch Centrum Utrecht | ||
Full Title: Unrelated cord blood transplantation after reduced toxicity conditioning with mesenchymal stromal cell co-infusion in patients with severe epidermolysis bullosa | ||
Medical condition: The source population consists of patients referred to or within the UMC Groningen because they have diagnosed clinically and genetically severe generalized RDEB. | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000095-17 | Sponsor Protocol Number: HOLOGENE17 | Start Date*: 2017-08-17 |
Sponsor Name:Holostem Terapie Avanzate s.r.l. | ||
Full Title: PROSPECTIVE, OPEN-LABEL, UNCONTROLLED CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF AUTOLOGOUS CULTURED EPIDERMAL GRAFTS CONTAINING EPIDERMAL STEM CELLS GENETICALLY MODIFIED WITH A GAMMA-RETR... | ||
Medical condition: JEB is genetically and clinically heterogeneous characterized by mutations in COL17A1,encoding for Collagen17 protein. COLXVII is a collagenous transmembrane type II protein component of the hemide... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012676-27 | Sponsor Protocol Number: FemExp-I | Start Date*: 2010-01-24 | ||||||||||||||||
Sponsor Name:Wallenberg laboratory | ||||||||||||||||||
Full Title: Femoral-Express-I | ||||||||||||||||||
Medical condition: Peripheral artery disease. Patients due for by-pass surgery of lower extremity arteries. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000087-16 | Sponsor Protocol Number: CA182-026 | Start Date*: 2009-03-16 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A randomized Discontinuation Study of Brivanib alaninate (BMS-582664) versus Placebo in Subjects with Advanced Tumors. Revised protocol 02 incorporating Amendment 02 & 03 & Administrative Lette... | |||||||||||||
Medical condition: Subjects with Advanced Solid Tumors | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) NL (Completed) FR (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003774-16 | Sponsor Protocol Number: EIFFEL | Start Date*: 2016-06-07 |
Sponsor Name:A.R.T.I.C. (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie ) | ||
Full Title: Phase I/II dose-finding, safety and efficacy study of radium-223 dichloride (XOFIGO®) in renal cell carcinoma patients with bone metastases | ||
Medical condition: Renal cell carcinoma patients with bone metastases, with or without visceral metastases. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004500-30 | Sponsor Protocol Number: ADSTEM001 | Start Date*: 2015-02-13 |
Sponsor Name:King's College London [...] | ||
Full Title: A phase I/II study evaluating allogeneic mesenchymal stromal cells in adults with recessive dystrophic epidermolysis bullosa | ||
Medical condition: Recessive dystrophic epidermolysis bullosa | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001978-28 | Sponsor Protocol Number: IEOS698/312 | Start Date*: 2012-11-05 | |||||||||||
Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA | |||||||||||||
Full Title: A Phase II study of intermittent letrozole plus transdermal estradiol gel 3 month-therapy as adjuvant endocrine treatment for postmenopausal women with hormone-receptor positive early stage breas... | |||||||||||||
Medical condition: Breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016748-38 | Sponsor Protocol Number: MAL-REG_01 | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:Free State of Bavaria rep. by the Univ. of Regensburg, rep. by the Regensburg Univ. Hospital | ||||||||||||||||||
Full Title: Prospective, randomized, placebo-controlled, monocentric, two-armed, observer-blinded and within-patient study for Photodynamic Therapy (PDT) with MAL in the treatment of actinic keratoses (AK) and... | ||||||||||||||||||
Medical condition: actinic keratoses and photoaged skin | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002695-37 | Sponsor Protocol Number: CLIN-60190-453 | Start Date*: 2023-04-27 | |||||||||||
Sponsor Name:Ipsen Bioscience, Inc. | |||||||||||||
Full Title: A Phase II, Multicenter, Double-Blind, Randomised, Placebo-Controlled Study and Open-Label Long Term Extension to Evaluate the Safety and Efficacy of Elafibranor in Adult Participants with Primary ... | |||||||||||||
Medical condition: Adults patients with Primary Sclerosing Cholangitis (PSC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010813-57 | Sponsor Protocol Number: RA0010 | Start Date*: 2009-08-28 | |||||||||||
Sponsor Name:UCB Celltech | |||||||||||||
Full Title: A multicenter, randomized, double-blind, placebo-controlled, single dose study to evaluate the pharmacokinetics, pharmacodynamics, safety and tolerability of intravenous and subcutaneous CDP6038 in... | |||||||||||||
Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003230-26 | Sponsor Protocol Number: MIV-711-201 | Start Date*: 2016-03-23 | |||||||||||
Sponsor Name:Medivir AB | |||||||||||||
Full Title: A Randomised, Double-blind Placebo-controlled Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of MIV-711 in Knee Joint Osteoarthritis | |||||||||||||
Medical condition: Knee Joint Osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.